Skip to main content
SpringerLink
Log in

Peripheral T cell lymphomas in elderly patients: a retrospective analysis from the Hematology Association of South East Korea (HASEK)

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

Limited data are available on the clinical features and the outcomes of elderly patients with peripheral T cell lymphomas (PTCLs). We identified PTCL patients of age 60 years or older from the records of the Hematology Association of South East Korea between 2001 and 2014. The median age of the patients (70.4 % male) was 71 years (range 60–88 years). The majority (80.2 %) had stage III/IV disease, and 61.7 % of patients had Charlson comorbidity index (CCI) score 0. Out of 74 patients treated with chemotherapy, 62 were administered anthracycline-based combination chemotherapy (CHOP: 47 patients, CHOEP: 15 patients), and 12 received non-anthracycline-based combination chemotherapy (IMEP: 8 patients, and CVP: 4 patients). The overall response rate for the 74 patients treated with chemotherapy was 70.2 % (CR 37.8 % and PR 32.4 %). With a median follow-up of 23.8 (range 0.5–156) months, the estimated 5-year progression-free survival (PFS) and overall survival (OS) were 16.6 and 45.9 %, respectively. There were no significant differences in PFS and OS between patients treated with anthracycline-based and non-anthracycline-based combination chemotherapy. In the univariate analysis, increased age, elevated serum lactate dehydrogenase, Eastern Cooperative Oncology Group performance status >1, higher CCI, high or high-intermediate IPI, and PIT groups 3–4 were associated with shorter OS. Our findings may provide valuable information on the management and outcomes of elderly patients with PTCL in clinical practice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Rodriguez-Abreu D, Filho VB, Zucca E (2008) Peripheral T-cell lymphomas, unspecified (or not otherwise specified): a review. Hematol Oncol 26(1):8–20. doi:10.1002/hon.836

    Article  CAS  PubMed  Google Scholar 

  2. Foss FM, Zinzani PL, Vose JM, Gascoyne RD, Rosen ST, Tobinai K (2011) Peripheral T-cell lymphoma. Blood 117(25):6756–6767. doi:10.1182/blood-2010-05-231548

    Article  CAS  PubMed  Google Scholar 

  3. Vose J, Armitage J, Weisenburger D (2008) International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol Off J Am Soc Clin Oncol 26(25):4124–4130. doi:10.1200/jco.2008.16.4558

    Article  Google Scholar 

  4. Savage KJ, Harris NL, Vose JM, Ullrich F, Jaffe ES, Connors JM, Rimsza L, Pileri SA, Chhanabhai M, Gascoyne RD, Armitage JO, Weisenburger DD (2008) ALK-anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project. Blood 111(12):5496–5504. doi:10.1182/blood-2008-01-134270

    Article  CAS  PubMed  Google Scholar 

  5. The International Non-Hodgkin’s Lymphoma Prognostic Factors Project (1993) A predictive model for aggressive non-Hodgkin’s lymphoma. N Engl J Med 329(14):987–994. doi:10.1056/nejm199309303291402

    Article  Google Scholar 

  6. Gallamini A, Stelitano C, Calvi R, Bellei M, Mattei D, Vitolo U, Morabito F, Martelli M, Brusamolino E, Iannitto E, Zaja F, Cortelazzo S, Rigacci L, Devizzi L, Todeschini G, Santini G, Brugiatelli M, Federico M (2004) Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. Blood 103(7):2474–2479. doi:10.1182/blood-2003-09-3080

    Article  CAS  PubMed  Google Scholar 

  7. Lee Y, Uhm JE, Lee HY, Park MJ, Kim H, Oh SJ, Jang JH, Kim K, Jung CW, Ahn YC, Park K, Ko YH, Kim WS (2009) Clinical features and prognostic factors of patients with “peripheral T cell lymphoma, unspecified”. Ann Hematol 88(2):111–119. doi:10.1007/s00277-008-0544-2

    Article  PubMed  Google Scholar 

  8. Weisenburger DD, Savage KJ, Harris NL, Gascoyne RD, Jaffe ES, MacLennan KA, Rudiger T, Pileri S, Nakamura S, Nathwani B, Campo E, Berger F, Coiffier B, Kim WS, Holte H, Federico M, Au WY, Tobinai K, Armitage JO, Vose JM (2011) Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project. Blood 117(12):3402–3408. doi:10.1182/blood-2010-09-310342

    Article  CAS  PubMed  Google Scholar 

  9. Hasselblom S, Ridell B, Nilsson-Ehle H, Andersson PO (2007) The impact of gender, age and patient selection on prognosis and outcome in diffuse large B-cell lymphoma—a population-based study. Leuk Lymphoma 48(4):736–745. doi:10.1080/10428190601187703

    Article  PubMed  Google Scholar 

  10. Gomez H, Hidalgo M, Casanova L, Colomer R, Pen DL, Otero J, Rodriguez W, Carracedo C, Cortes-Funes H, Vallejos C (1998) Risk factors for treatment-related death in elderly patients with aggressive non-Hodgkin’s lymphoma: results of a multivariate analysis. J Clin Oncol Off J Am Soc Clin Oncol 16(6):2065–2069

    CAS  Google Scholar 

  11. Balducci L (2010) ESH-SIOG international conference on haematological malignancies in the elderly. Expert Rev Hematol 3(6):675–677. doi:10.1586/ehm.10.72

    Article  PubMed  Google Scholar 

  12. Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, Coiffier B, Fisher RI, Hagenbeek A, Zucca E, Rosen ST, Stroobants S, Lister TA, Hoppe RT, Dreyling M, Tobinai K, Vose JM, Connors JM, Federico M, Diehl V (2007) Revised response criteria for malignant lymphoma. J Clin Oncol Off J Am Soc Clin Oncol 25(5):579–586. doi:10.1200/jco.2006.09.2403

    Article  Google Scholar 

  13. Thieblemont C, Grossoeuvre A, Houot R, Broussais-Guillaumont F, Salles G, Traulle C, Espinouse D, Coiffier B (2008) Non-Hodgkin’s lymphoma in very elderly patients over 80 years. A descriptive analysis of clinical presentation and outcome. Ann Oncol 19(4):774–779. doi:10.1093/annonc/mdm563

    Article  CAS  PubMed  Google Scholar 

  14. Diem S, Ess S, Cerny T, Fruh M, Hitz F (2014) Diffuse large B-cell lymphoma in elderly patients: a retrospective analysis. Eur J Intern Med 25(6):577–582. doi:10.1016/j.ejim.2014.05.001

    Article  CAS  PubMed  Google Scholar 

  15. Luminari S, Cesaretti M, Rashid I, Mammi C, Montanini A, Barbolini E, Bellei M, Pennese E, Sirotti MA, Marcheselli L, Partesotti G, Bari A, Maiorana A, Bonacorsi G, Federico M (2007) Incidence, clinical characteristics and survival of malignant lymphomas: a population-based study from a cancer registry in northern Italy. Hematol Oncol 25(4):189–197. doi:10.1002/hon.826

    Article  PubMed  Google Scholar 

  16. Peters FP, Lalisang RI, Fickers MM, Erdkamp FL, Wils JA, Houben SG, Wals J, Schouten HC (2001) Treatment of elderly patients with intermediate- and high-grade non-Hodgkin’s lymphoma: a retrospective population-based study. Ann Hematol 80(3):155–159

    Article  CAS  PubMed  Google Scholar 

  17. Extermann M, Hurria A (2007) Comprehensive geriatric assessment for older patients with cancer. J Clin Oncol Off J Am Soc Clin Oncol 25(14):1824–1831. doi:10.1200/jco.2007.10.6559

    Article  Google Scholar 

  18. Tucci A, Ferrari S, Bottelli C, Borlenghi E, Drera M, Rossi G (2009) A comprehensive geriatric assessment is more effective than clinical judgment to identify elderly diffuse large cell lymphoma patients who benefit from aggressive therapy. Cancer 115(19):4547–4553. doi:10.1002/cncr.24490

    Article  PubMed  Google Scholar 

  19. Vose JM (2008) Peripheral T-cell non-Hodgkin’s lymphoma. Hematol Oncol Clin North Am 22 (5):997–1005, x. doi:10.1016/j.hoc.2008.07.010

  20. Suzumiya J, Ohshima K, Tamura K, Karube K, Uike N, Tobinai K, Gascoyne RD, Vose JM, Armitage JO, Weisenburger DD (2009) The International Prognostic Index predicts outcome in aggressive adult T-cell leukemia/lymphoma: analysis of 126 patients from the International Peripheral T-Cell Lymphoma Project. Ann Oncol 20(4):715–721. doi:10.1093/annonc/mdn696

    Article  CAS  PubMed  Google Scholar 

  21. O’Connor OA, Pro B, Pinter-Brown L, Bartlett N, Popplewell L, Coiffier B, Lechowicz MJ, Savage KJ, Shustov AR, Gisselbrecht C, Jacobsen E, Zinzani PL, Furman R, Goy A, Haioun C, Crump M, Zain JM, Hsi E, Boyd A, Horwitz S (2011) Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study. J Clin Oncol Off J Am Soc Clin Oncol 29(9):1182–1189. doi:10.1200/jco.2010.29.9024

    Article  Google Scholar 

  22. Piekarz RL, Frye R, Prince HM, Kirschbaum MH, Zain J, Allen SL, Jaffe ES, Ling A, Turner M, Peer CJ, Figg WD, Steinberg SM, Smith S, Joske D, Lewis I, Hutchins L, Craig M, Fojo AT, Wright JJ, Bates SE (2011) Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma. Blood 117(22):5827–5834. doi:10.1182/blood-2010-10-312603

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Zinzani PL, Pellegrini C, Broccoli A, Stefoni V, Gandolfi L, Quirini F, Argnani L, Berti E, Derenzini E, Pileri S, Baccarani M (2011) Lenalidomide monotherapy for relapsed/refractory peripheral T-cell lymphoma not otherwise specified. Leuk Lymphoma 52(8):1585–1588. doi:10.3109/10428194.2011.573031

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Eun Hee Lee, Eun Kyoung Kang, and Mi Seon Jeon for assisting with the data collection and management. This paper was supported by the Dong-A University Research Fund.

Author information

Authors and Affiliations

  1. Department of Hematology and Oncology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, South Korea

    Jae-Cheol Jo, Yunsuk Choi & Hawk Kim

  2. Department of Hematology and Oncology, Busan National University Hospital, Busan, South Korea

    Ho-Jin Shin

  3. Department of Hematology and Oncology, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, South Korea

    Sung Nam Yhim

  4. Department of Hematology and Oncology, Kosin University Gospel Hospital, Busan, South Korea

    Ho Sup Lee

  5. Department of Hematology and Oncology, Busan Paik Hospital, Inje University College of Medicine, Busan, South Korea

    Won-Sik Lee

  6. Department of Hematology and Oncology, Dong-A University College of Medicine, 26, Daesingongwon-ro, Seo-gu, Busan, 49201, South Korea

    Ji-Hyun Lee & Sung Yong Oh

Authors
  1. Jae-Cheol Jo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yunsuk Choi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ho-Jin Shin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sung Nam Yhim
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ho Sup Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Won-Sik Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ji-Hyun Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hawk Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Sung Yong Oh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sung Yong Oh.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jo, JC., Choi, Y., Shin, HJ. et al. Peripheral T cell lymphomas in elderly patients: a retrospective analysis from the Hematology Association of South East Korea (HASEK). Ann Hematol 95, 619–624 (2016). https://doi.org/10.1007/s00277-016-2597-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-016-2597-y

Keywords

Search

Navigation